Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and ...

Looking for value in crypto without breaking the bank? This guide dives into BlockDAG, Ethena, Hedera, and Stellar, which are ...

Owing to Briumvi's solid launch, TG's balance sheet is in excellent condition. Despite new competition, Briumvi's five-year ...

July was a roller coaster for New York City FC. In Major League Soccer, the team won two road games while going 3-1-1, ...

This opportunity has now been extended through December 31, 2025, with $713,405 remaining thanks to an individual gift match ...

Lancaster is hosting an open house Wednesday, July 30, to gather public opinions on converting nine city streets from one-way ...

Humanitarian aid organizations and international bodies have warned that Gaza is facing "critical" levels of hunger and that ...

From Iron Man to Quantumania, here’s every MCU phase-opening movie ranked by worldwide box office – just ahead of Fantastic Four and Phase 6.

Kapil Sharma’s story isn’t just about a number on the scale. It’s a reminder that even for someone with sleepless nights and ...

Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening ...

Rail projects across the United States are billions over budget and more than a decade behind scheduled completion.

GSK’s cobolimab has become the latest anti-TIM-3 antibody to flunk a crucial oncology test, as the pharma absorbs a more than $600 million hit from its anti-TIGIT drug failure. | GSK’s cobolimab has ...